About Us

Archives






Zivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced…

Posted: July 5, 2021 at 1:51 am


KEEGO HARBOR, Mich., July 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, today announced the closing of the sale of an additional 150,000 shares of common stock, at a price to the public of $4.99 per share less underwriting discounts and commissions, pursuant to the partial exercise of the underwriters’ over-allotment option in connection with its previously announced public offering that closed on June 2, 2021. ZIVO received gross proceeds of approximately $748,500, before deducting underwriting discounts and commissions and other estimated offering expenses.

Read this article:
Zivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced...

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.